Asia Pacific Digital Respiratory Devices Market Size, Share, and COVID-19 Impact Analysis, By Product (Smart Inhalers & Nebulizers and Sensors & Apps), By Disease Indication (Asthma, COPD, and Other Diseases), By End Use (Hospitals, Home Care Settings, and Other Settings), and Asia Pacific Digital Respiratory Devices Market Insights, Industry Trend, Forecasts to 2035

Asia Pacific Digital Respiratory Devices Market Insights Forecasts to 2035

• The Asia Pacific Digital Respiratory Devices Market Size was Estimated at USD 10.2 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 30.92% from 2025 to 2035
• The Asia Pacific Digital Respiratory Devices Market Size is Expected to Reach USD 197.5 Billion by 2035

According to a research report published by Spherical Insights & Consulting, the Asia Pacific Digital Respiratory Devices Market Size is Anticipated to Reach USD 197.5 Billion by 2035, Growing at a CAGR of 30.92% from 2025 to 2035. The prevalence of chronic respiratory diseases such as COPD & asthma, along with increasing technological advancements in connected devices, aids in driving the digital respiratory devices market in the Asia Pacific region.

Market Overview

The Asia Pacific digital respiratory devices market is the market for medical devices that use digital technology like sensors, Bluetooth, and AI for monitoring, managing, and treating chronic respiratory conditions. Digital respiratory devices include smart inhalers and digital spirometers in which sensors and other electronic components are incorporated for monitoring respiratory health and treatment for asthma and COPD respiratory conditions. With the rising awareness regarding respiratory health, an increasing need for remote monitoring solutions is aiding in propelling the market of digital respiratory devices. Emergence of telemedicine and remote patient monitoring to collect patient health data from home and transmit the data electronically to the healthcare providers, to improve healthcare decision-making, is bolstering the market growth opportunity.

Report Coverage

This research report categorizes the market for the Asia Pacific digital respiratory devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Asia Pacific digital respiratory devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Asia Pacific digital respiratory devices market.

Driving Factors

The significant prevalence of respiratory conditions like COPD and asthma due to factors like increasing smoking rate in the epidemic, increased rates of indoor air pollution, and demographic shifts is anticipated to drive the market demand. Technological advancements, including the integration of AI and sensors as well as mobile platforms for enabling personalized, remote patient monitoring, are propelling the market growth. Additionally, an increasing awareness about respiratory health, along with significant issues in the regions, including smoking-related diseases, air pollution, and respiratory infections, is contributing to promoting the market.

Restraining Factors

The lack of reimbursement policies for the devices and increased cost restricts their adoption in the emerging economies, which ultimately hampers the market growth. Further, concerns regarding data privacy and protection are challenging the market.

Market Segmentation

The Asia Pacific digital respiratory devices market share is classified into product, disease indication, and end use.

• The smart inhalers and nebulizers segment held the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific digital respiratory devices market is segmented by product into smart inhalers & nebulizers and sensors & apps. Among these, the smart inhalers and nebulizers segment held the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. Digitalization of inhalers and nebulizers is enhancing their functionality, enabling better medication usage and compliance monitoring for effective disease management. Introduction of digital e-health solutions in respiratory devices is contributing propelling the market growth.

• The COPD segment held the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific digital respiratory devices market is segmented by disease indication into asthma, COPD, and other diseases. Among these, the COPD segment held the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. COPD is a major health issue with substantial prevalence, especially in East Asia and the Pacific, due to factors like tobacco smoking, indoor air pollution, occupational dust, and genetic factors.

• The hospitals segment held the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific digital respiratory devices market is segmented by end use into hospitals, home care settings, and other settings. Among these, the hospitals segment held the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. Digital technology enhances communication among healthcare providers and patients in hospitals. Further, healthcare infrastructure, public-private partnerships, and service accessibility are several factors that are driving the market in the hospitals segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Asia Pacific digital respiratory devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Philips
• 3M Healthcare
• Astra Zenca Plc.
• Novartis AG
• GE Healthcare
• Masimo Corporation
• Cipla Ltd.
• Resmed Ltd.
• Teva Pharmaceuticals Industries Ltd.
• Acorda Therapeutics
• Others

Recent Developments:

• In November 2024, ResMed, leading health technology company focused on sleep, breathing, and care delivered in the home, has reaffirmed its commitment to expanding the company’s Singapore operations.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Asia Pacific, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Asia Pacific Digital Respiratory Devices Market based on the below-mentioned segments:

Asia Pacific Digital Respiratory Devices Market, By Product

• Smart Inhalers & Nebulizers
• Sensors & Apps

Asia Pacific Digital Respiratory Devices Market, By Disease Indication

• Asthma
• COPD
• Other Diseases

Asia Pacific Digital Respiratory Devices Market, By End Use

• Hospitals
• Home Care Settings
• Other Settings